News
Regulatory affairsRegulatory Round-up - July 2026
MHRA introduces regulations that allow decentralised manufacturing of therapiesCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Ed Samuel as Chief Operating OfficerSpliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotCGT Catapult response to publication of the Life Sciences Sector PlanCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformRegulatory Round-up - June 2025From nascent to mainstream: Overcoming barriers in iPSC therapy developmentScience Minister Lord Vallance opens Digital and Automation Testbeds that will improve advanced therapies manufacturingRegulatory Round-up - May 2025The digital revolution in cell and gene therapy: Insights from Advanced Therapies Integrates NorthIan Murray MP visits the Cell and Gene Therapy Catapult, learning about its work supporting the advanced therapy sector